Investor · 1 deal
Every published round Dr Stephen Thompson took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Longas | Unnamed stage | 16 May 2019 | - | Participant | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Companies Dr Stephen Thompson has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Longas | 16 May 2019 | 1 | 0 |
Fund closes reported for Dr Stephen Thompson, as distinct from the investments it has made.
Companies Dr Stephen Thompson has backed that another company then bought. An exit for the holding, not a deal Dr Stephen Thompson did.
Stories naming Dr Stephen Thompson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A university spin-out launches with venture and founder backing, introducing a technology that extends DNA sequencing read lengths, and appointing a new chief executive to commercialise it.